SMS Pharmaceuticals is currently trading at Rs. 84.65, up by 11.65 points or 15.96% from its previous closing of Rs. 73.00 on the BSE.
The scrip opened at Rs. 74.00 and has touched a high and low of Rs. 87.60 and Rs. 73.95 respectively. So far 181934 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 115.00 on 06-Oct-2016 and a 52 week low of Rs. 66.60 on 11-Aug-2017.
Last one week high and low of the scrip stood at Rs. 87.60 and Rs. 70.25 respectively. The current market cap of the company is Rs. 676.37 crore.
The promoters holding in the company stood at 67.99% while Institutions and Non-Institutions held 0.18% and 31.83% respectively.
SMS Pharmaceuticals’ manufacturing facility-Unit II located at Bachupally, Ranga Reddy District, Hyderabad, Telangana, India was successfully inspected by Pharmaceuticals and Medical Devices Agency (PMDA), Japan Authorities. The inspection was carried out between July 25, 2017 to July 27, 2017.
SMS Pharmaceuticals is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. They are the single largest producer of anti-ulcer products.
PMDA inspects SMS Pharmaceuticals’ manufacturing facility at Telangana
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: